Cargando…
Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis
BACKGROUND: MicroRNAs (miRNAs) negatively regulate the 3′ untranslated region (3′-UTR) of coding genes by suppressing translation or degrading mRNAs, and they act as oncogenes or tumor suppressors. Recently, several studies investigated the association between pre-miR-27a rs895819 polymorphism and t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676439/ https://www.ncbi.nlm.nih.gov/pubmed/23762318 http://dx.doi.org/10.1371/journal.pone.0065208 |
_version_ | 1782272640354877440 |
---|---|
author | Xu, Qian He, Cai-yun Liu, Jing-wei Yuan, Yuan |
author_facet | Xu, Qian He, Cai-yun Liu, Jing-wei Yuan, Yuan |
author_sort | Xu, Qian |
collection | PubMed |
description | BACKGROUND: MicroRNAs (miRNAs) negatively regulate the 3′ untranslated region (3′-UTR) of coding genes by suppressing translation or degrading mRNAs, and they act as oncogenes or tumor suppressors. Recently, several studies investigated the association between pre-miR-27a rs895819 polymorphism and the risks of various cancers, but the results were inconsistent. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a meta-analysis of 13 studies that included 6501 cancer cases and 7571 controls to address this association. Overall, this meta-analysis showed that the pre-miR-27a rs895819 A/G polymorphism was not statistically associated with cancers risk in all genetic models. In the stratified analysis by cancer types, when compared with the ancestral A allele, individuals with the variant G allele was consistently associated with reduced risks of breast cancer (OR = 0.92, 95% CI = 0.85–0.99), renal cell cancer (OR = 0.81, 95% CI = 0.67–0.97) and nasopharyngeal cancer (OR = 0.84, 95% CI = 0.72–0.97). Inversely, individuals with the heterozygote AG was associated with an increased risk of digestive tract cancers compared with AA genotype (AG vs. AA: OR = 1.16, 95% CI = 1.01–1.32). In the stratified analysis by ethnicity, the pre-miR-27a rs895819 polymorphism showed statistically significant association with decreased risks of cancers in Caucasians (G vs. A allele: OR = 0.90, 95% CI = 0.83–0.97; AG vs. AA: OR = 0.84, 95% CI = 0.75–0.94; AG/GG vs. AA: OR = 0.85, 95% CI = 0.76–0.94) but not in Asians. CONCLUSION/SIGNIFICANCE: This meta-analysis suggests that the pre-miR-27a rs895819 polymorphism may contribute to the susceptibilities of some specific-type of cancers, including breast cancer, renal cell cancer, nasopharyngeal cancer and digestive tract cancers, as well as the susceptibilities of cancers in Caucasians to some extent. |
format | Online Article Text |
id | pubmed-3676439 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-36764392013-06-12 Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis Xu, Qian He, Cai-yun Liu, Jing-wei Yuan, Yuan PLoS One Research Article BACKGROUND: MicroRNAs (miRNAs) negatively regulate the 3′ untranslated region (3′-UTR) of coding genes by suppressing translation or degrading mRNAs, and they act as oncogenes or tumor suppressors. Recently, several studies investigated the association between pre-miR-27a rs895819 polymorphism and the risks of various cancers, but the results were inconsistent. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a meta-analysis of 13 studies that included 6501 cancer cases and 7571 controls to address this association. Overall, this meta-analysis showed that the pre-miR-27a rs895819 A/G polymorphism was not statistically associated with cancers risk in all genetic models. In the stratified analysis by cancer types, when compared with the ancestral A allele, individuals with the variant G allele was consistently associated with reduced risks of breast cancer (OR = 0.92, 95% CI = 0.85–0.99), renal cell cancer (OR = 0.81, 95% CI = 0.67–0.97) and nasopharyngeal cancer (OR = 0.84, 95% CI = 0.72–0.97). Inversely, individuals with the heterozygote AG was associated with an increased risk of digestive tract cancers compared with AA genotype (AG vs. AA: OR = 1.16, 95% CI = 1.01–1.32). In the stratified analysis by ethnicity, the pre-miR-27a rs895819 polymorphism showed statistically significant association with decreased risks of cancers in Caucasians (G vs. A allele: OR = 0.90, 95% CI = 0.83–0.97; AG vs. AA: OR = 0.84, 95% CI = 0.75–0.94; AG/GG vs. AA: OR = 0.85, 95% CI = 0.76–0.94) but not in Asians. CONCLUSION/SIGNIFICANCE: This meta-analysis suggests that the pre-miR-27a rs895819 polymorphism may contribute to the susceptibilities of some specific-type of cancers, including breast cancer, renal cell cancer, nasopharyngeal cancer and digestive tract cancers, as well as the susceptibilities of cancers in Caucasians to some extent. Public Library of Science 2013-06-07 /pmc/articles/PMC3676439/ /pubmed/23762318 http://dx.doi.org/10.1371/journal.pone.0065208 Text en © 2013 Xu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Xu, Qian He, Cai-yun Liu, Jing-wei Yuan, Yuan Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis |
title | Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis |
title_full | Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis |
title_fullStr | Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis |
title_full_unstemmed | Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis |
title_short | Pre-miR-27a rs895819A/G Polymorphisms in Cancer: A Meta-Analysis |
title_sort | pre-mir-27a rs895819a/g polymorphisms in cancer: a meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676439/ https://www.ncbi.nlm.nih.gov/pubmed/23762318 http://dx.doi.org/10.1371/journal.pone.0065208 |
work_keys_str_mv | AT xuqian premir27ars895819agpolymorphismsincancerametaanalysis AT hecaiyun premir27ars895819agpolymorphismsincancerametaanalysis AT liujingwei premir27ars895819agpolymorphismsincancerametaanalysis AT yuanyuan premir27ars895819agpolymorphismsincancerametaanalysis |